Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment

This publication has 17 references indexed in Scilit:

• Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
  Case Reports in Cardiology, 2016
• Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential
  Heart Rhythm, 2015
• Assessment of temperature‐induced hERG channel blockade variation by drugs
  Journal of Applied Toxicology, 2014
• Suspected Hydroxychloroquine-Associated QT-Interval Prolongation in a Patient With Systemic Lupus Erythematosus
  JCR: Journal of Clinical Rheumatology, 2013
• Cardiovascular Risks with Azithromycin and Other Antibacterial Drugs
  New England Journal of Medicine, 2013
• Azithromycin and the Risk of Cardiovascular Death
  New England Journal of Medicine, 2012
• Azithromycin‐Induced Torsade De Pointes
  Pacing and Clinical Electrophysiology, 2007
• Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors
  Journal of Interventional Cardiac Electrophysiology, 2007
• Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular Arrhythmia
  Clinical Toxicology, 2006
• Polymorphic Ventricular Tachycardia with a Normal QT Interval Following Azithromycin
  Pacing and Clinical Electrophysiology, 2005